Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Operative Care Division and Research and Development Division, Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.122130.
Acute cardiorenal syndrome (CRS-1) is a morbid complication of acute cardiovascular disease. Heart-to-kidney signals transmitted by "cardiorenal connectors" have been postulated, but investigation into CRS-1 has been limited by technical limitations and a paucity of models. To address these limitations, we developed a translational model of CRS-1, cardiac arrest and cardiopulmonary resuscitation (CA/CPR), and now report findings from nanoscale mass spectrometry proteomic exploration of glomerular filtrate 2 hours after CA/CPR or sham procedure. Filtrate acquisition was confirmed by imaging, molecular weight and charge distribution, and exclusion of protein specific to surrounding cells. Filtration of proteins specific to the heart was detected following CA/CPR and confirmed with mass spectrometry performed using urine collections from mice with deficient tubular endocytosis. Cardiac LIM protein was a CA/CPR-specific filtrate component. Cardiac arrest induced plasma release of cardiac LIM protein in mice and critically ill human cardiac arrest survivors, and administration of recombinant cardiac LIM protein to mice altered renal function. These findings demonstrate that glomerular filtrate is accessible to nanoscale proteomics and elucidate the population of proteins filtered 2 hours after CA/CPR. The identification of cardiac-specific proteins in renal filtrate suggests a novel signaling mechanism in CRS-1. We expect these findings to advance understanding of CRS-1.
急性心肾综合征(CRS-1)是急性心血管疾病的一种严重并发症。“心肾连接”所传递的心肾信号已被提出,但由于技术限制和模型不足,对 CRS-1 的研究受到限制。为了解决这些限制,我们开发了一种 CRS-1、心脏骤停和心肺复苏(CA/CPR)的转化模型,现在报告 CA/CPR 或假手术 2 小时后肾小球滤过液的纳米质谱蛋白质组学探索结果。滤过液的采集通过成像、分子量和电荷分布以及排除周围细胞特有的蛋白质来确认。在 CA/CPR 后检测到心脏特有的蛋白质的滤过,并使用来自肾小管内吞作用缺陷的小鼠的尿液收集进行质谱分析来证实。心脏 LIM 蛋白是 CA/CPR 特异性滤过成分。心脏骤停诱导小鼠和危重心律失常患者的心脏 LIM 蛋白血浆释放,并向小鼠施用重组心脏 LIM 蛋白改变肾功能。这些发现表明纳米尺度蛋白质组学可用于肾小球滤过液,阐明 CA/CPR 后 2 小时滤过的蛋白质群。在肾滤过液中鉴定出心脏特异性蛋白提示 CRS-1 中存在新的信号机制。我们希望这些发现能够促进对 CRS-1 的理解。